Prospective Motion Correction in MRI using a new optical motion-tracking system

• Conditions: G40; I63; Epilepsy; Cerebral infarction

• Registration Number: DRKS00005007
• Lead Sponsor: Abteilung Neuroradiologie, Uniklinik Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2013-09-13
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 750

Inclusion Criteria

Healthy controls 18 years or older and patients with no age limit, that are able to consent. In patients not able to consent the consent of a parent or legal guardian is required.
a) Healthy subjects 18 years and older for the pilot phase
b) Patients in the 9.5 hour time window of acute stroke
c) Patients with no age limit for evaluation of epileptogenic focus.
d) Paediatric patients with an indication for clinical routine mri and existing signed consent from a parent or legal guardian.

Exclusion Criteria

Contraindication for MRI as stated in the written informed consent (for example pacemaker, medical pumps or pregnancy).

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical assesment of a new optical motion tracking system within the MRI diagnostic routine.

Secondary Outcome Measures

Name	Time	Method
Evaluation of the quality of MR images using a new optical motion tracking system to minimize motion artifacts in intra-individual comparison with conventional MR imaging.